Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy

In recent decades, important advances have been made in the diagnosis and treatment of invasive aspergillosis (IA) and mucormycosis. One of these advances has been the introduction of isavuconazole, a second-generation broad spectrum triazole with a favorable pharmacokinetic and safety profile and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenks, Jeffrey D, Salzer, Helmut JF, Prattes, Juergen, Krause, Robert, Buchheidt, Dieter, Hoenigl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933337/
https://www.ncbi.nlm.nih.gov/pubmed/29750016
http://dx.doi.org/10.2147/DDDT.S145545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933337/
https://www.ncbi.nlm.nih.gov/pubmed/29750016
http://dx.doi.org/10.2147/DDDT.S145545

Ejemplares similares